DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure

BACKGROUND: It remains to be elucidated whether dipeptidylpeptidase-4 (DPP-4) inhibitor can ameliorate cardiovascular injury in salt-sensitive hypertension. The present study was undertaken to test our hypothesis that linagliptin, a DPP-4 inhibitor, administration initiated after onset of hypertensi...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Cardiovasc Diabetol
मुख्य लेखकों: Koibuchi, Nobutaka, Hasegawa, Yu, Katayama, Tetsuji, Toyama, Kensuke, Uekawa, Ken, Sueta, Daisuke, Kusaka, Hiroaki, Ma, MingJie, Nakagawa, Takashi, Lin, Bowen, Kim-Mitsuyama, Shokei
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2014
विषय:
Original Investigation
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC4255443/
https://ncbi.nlm.nih.gov/pubmed/25471116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-014-0157-0
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन